Twitter IconLinkedIn logo for website footers

September 19 – 21, 2017
Boston, USA

Content Library


  • Making Real World Evidence Analytics work

    A guide for Pharmaceutical and Biotechnology executives – Saama

  • Exclusive Interview with EMD Serono’s VP & Head of HEOR

    Julie Locklear discusses the why’s and how’s of RWE-based approaches and decision-making in drug life cycle management, including:

    -The great potential of leveraging this insight in innovative ways

    -The major challenges of harnessing analytics to optimize commercial and strategic considerations in the late stages of drug development

    -How she expects the field to evolve in the future

  • Past Presentations Pack

    Includes insightful presentations on:

    1) Developing a team and infrastructure to facilitate Real World Data (RWD) analytics in order to gain insights to enable decision making and improved patient care

    Ryan Copping, Global Head of RWD Analytics, Roche/Genentech


    2) Identifying Drug-Related Safety Signals Using Real-World Evidence and Advanced Analytics

    Abhik Bhattacharya, Senior Director & Global Head of Analytics, Astellas US LLC

  • Advanced Pharma Analytics EU Past Presentations Pack

    Presentations from the European meeting on:

    Real World Data – Role of Collaborations: A Pharma Perspective
    By Linda McNamara, Global Head, Strategic Collaborations & Excellence, Real World Data Science, Roche

    Real World Data and Prediction: Challenges and Opportunities
    By Tjeerd Van Staa, Professor, Health eResearch, University of Manchester

    Use of Social Media Beyond Pharmacovigilance
    By Valery Risson, Health Economics Manager, Novartis